PRESS RELEASE published on 11/21/2025 at 15:23, 9 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses owning 1.67% of Mural Oncology plc's shares. Form 8.3 filed with the Irish Takeover Panel Form 8.3 Irish Takeover Panel Vanguard Group Security Disclosure Mural Oncology Plc
PRESS RELEASE published on 11/21/2025 at 15:21, 9 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Just Group plc The Vanguard Group, Inc. discloses 5.36% ownership in Just Group plc as of 20 Nov 2025, selling 46,839 securities at 2.14 GBP per unit on 21 Nov 2025 The Vanguard Group Ownership Disclosure Financial Disclosure Securities Sale Just Group Plc
PRESS RELEASE published on 11/21/2025 at 15:20, 9 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc The Vanguard Group, Inc. discloses 1.22% ownership in International Personal Finance plc. Sale of 48,077 10p ordinary shares at 2.06 GBP per unit Financial Dealings Vanguard Group Ownership Disclosure Stock Sale International Personal Finance Plc
PRESS RELEASE published on 11/21/2025 at 15:19, 9 months 26 days ago Form 8.3 - The Vanguard Group, Inc.: Unite Group plc, The The Vanguard Group, Inc. discloses a 4.95% ownership position in Unite Group plc, The. Form 8.3 filed on 21-Nov-2025 Form 8.3 Vanguard Group Financial Disclosure Ownership Unite Group Plc
BRIEF published on 11/20/2025 at 15:56, 9 months 27 days ago The Vanguard Group Discloses Position in Qualcomm Securities Form 8.3 Takeover Code Vanguard Group Qualcomm
BRIEF published on 11/20/2025 at 15:55, 9 months 27 days ago The Vanguard Group's Disclosure on American Axle & Manufacturing Holdings, Inc. Form 8.3 The Vanguard Group Securities Disclosure Stock Transactions American Axle & Manufacturing
BRIEF published on 11/20/2025 at 15:53, 9 months 27 days ago The Vanguard Group Discloses Position in JTC plc Takeover Code Securities Disclosure Vanguard Group Financial Holdings JTC Plc
BRIEF published on 11/20/2025 at 15:51, 9 months 27 days ago The Vanguard Group Discloses Position in Avadel Pharmaceuticals Form 8.3 Irish Takeover Panel Securities Disclosure Vanguard Group Avadel Pharmaceuticals
PRESS RELEASE published on 11/20/2025 at 15:51, 9 months 27 days ago Form 8.3 - The Vanguard Group, Inc.: Qualcomm Incorporated The Vanguard Group, Inc. discloses 10.67% stake in Qualcomm Incorporated as of 19 November 2025. Purchase and sale of USD 0.0001 common shares The Vanguard Group Stake Disclosure Stock Transactions Investment Disclosure Qualcomm Incorporated
BRIEF published on 11/20/2025 at 15:50, 9 months 27 days ago The Vanguard Group Discloses Position in Mural Oncology plc Form 8.3 Vanguard Group Shareholding Irish Takeover Mural Oncology
Published on 09/17/2026 at 22:15, 1 hour 35 minutes ago Rocky Shore Gold Announces Non-Brokered Private Placement
Published on 09/17/2026 at 22:15, 1 hour 35 minutes ago Vanta Attends 2026 All-In Summit in Los Angeles, a Leading Gathering of Business, Investment and Industry Leaders
Published on 09/17/2026 at 22:05, 1 hour 45 minutes ago Loop Industries Forms Strategic Alternatives Committee to Maximize Shareholder Value
Published on 09/17/2026 at 15:55, 7 hours 55 minutes ago Empress Announces Agreement to Acquire Tongon Gold Stream and Secures Debt Financing
Published on 09/17/2026 at 15:25, 8 hours 25 minutes ago AIAI Holdings' Constellation Network Launches Dôr Patient Journey with Proactive MD(R), Expanding Transformational AI In Healthcare
Published on 09/17/2026 at 19:00, 4 hours 50 minutes ago Max Verstappen Passes All 100 Karts in 14 Laps in Red Bull's Max vs 100
Published on 09/17/2026 at 18:58, 4 hours 51 minutes ago EQS-Adhoc: H2APEX Group SCA: General Partner of H2APEX Group SCA resolves to prepare for the transfer of its stock exchange listing from the Regulated Market (Prime Standard) to the Scale segment of the Frankfur
Published on 09/17/2026 at 18:25, 5 hours 25 minutes ago Magentic raises $18M to build the AI workforce for the physical world
Published on 09/17/2026 at 18:10, 5 hours 40 minutes ago A robust adjusted EBIT margin of 18.8%, driven by solid organic revenue growth of 7.4%
Published on 09/17/2026 at 17:46, 6 hours 4 minutes ago RBI categorically denies the allegations of short-seller report
Published on 09/17/2026 at 17:40, 6 hours 10 minutes ago Eiffage wins a second contract, as part of the NSORe joint venture, for an offshore converter station in Germany
Published on 09/16/2026 at 17:45, 1 day 6 hours ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 16 hours ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
